Bausch Health Companies Inc (BHC)
8.09
-0.09
(-1.10%)
USD |
NYSE |
Nov 22, 14:51
Bausch Health Shareholders Equity (Quarterly): -1.174B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -1.174B |
June 30, 2024 | -1.175B |
March 31, 2024 | -1.115B |
December 31, 2023 | -1.022B |
September 30, 2023 | -1.18B |
June 30, 2023 | -663.00M |
March 31, 2023 | -800.00M |
December 31, 2022 | -692.00M |
September 30, 2022 | -525.00M |
June 30, 2022 | -693.00M |
March 31, 2022 | -216.00M |
December 31, 2021 | -106.00M |
September 30, 2021 | -204.00M |
June 30, 2021 | -687.00M |
March 31, 2021 | -197.00M |
December 31, 2020 | 535.00M |
September 30, 2020 | 587.00M |
June 30, 2020 | 474.00M |
March 31, 2020 | 719.00M |
December 31, 2019 | 1.063B |
September 30, 2019 | 2.482B |
June 30, 2019 | 2.601B |
March 31, 2019 | 2.693B |
December 31, 2018 | 2.733B |
September 30, 2018 | 3.153B |
Date | Value |
---|---|
June 30, 2018 | 3.467B |
March 31, 2018 | 4.424B |
December 31, 2017 | 5.849B |
September 30, 2017 | 5.327B |
June 30, 2017 | 3.931B |
March 31, 2017 | 3.893B |
December 31, 2016 | 3.152B |
September 30, 2016 | 4.167B |
June 30, 2016 | 5.296B |
March 31, 2016 | 5.656B |
December 31, 2015 | 5.91B |
September 30, 2015 | 6.342B |
June 30, 2015 | 6.435B |
March 31, 2015 | 6.452B |
December 31, 2014 | 5.279B |
September 30, 2014 | 5.123B |
June 30, 2014 | 5.258B |
March 31, 2014 | 5.090B |
December 31, 2013 | 5.119B |
September 30, 2013 | 4.949B |
June 30, 2013 | 5.703B |
March 31, 2013 | 3.587B |
December 31, 2012 | 3.717B |
September 30, 2012 | 3.785B |
June 30, 2012 | 3.695B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.18B
Minimum
Sep 2023
1.063B
Maximum
Dec 2019
-353.55M
Average
-594.00M
Median
Shareholders Equity (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 388.00M |
Edesa Biotech Inc | 2.867M |
Lexaria Bioscience Corp | 10.12M |
Xenon Pharmaceuticals Inc | 797.81M |
ESSA Pharma Inc | 128.86M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 26.54B |
Total Liabilities (Quarterly) | 26.78B |
Debt to Equity Ratio | -18.32 |
Current Ratio | 1.188 |
Net Debt Paydown Yield | -6.37% |